Article Versions Notes

Dubinin MV, Starinets VS, Belosludtseva NV, Mikheeva IB, Chelyadnikova YA, Igoshkina AD, Vafina AB, Vedernikov AA, Belosludtsev KN. BK_Ca Activator NS1619 Improves the Structure and Function of Skeletal Muscle Mitochondria in Duchenne Dystrophy. Pharmaceutics. 2022; 14(11):2336. https://doi.org/10.3390/pharmaceutics14112336

Dubinin, Mikhail V., Vlada S. Starinets, Natalia V. Belosludtseva, Irina B. Mikheeva, Yuliya A. Chelyadnikova, Anastasia D. Igoshkina, Aliya B. Vafina, Alexander A. Vedernikov, and Konstantin N. Belosludtsev. 2022. "BK_Ca Activator NS1619 Improves the Structure and Function of Skeletal Muscle Mitochondria in Duchenne Dystrophy" Pharmaceutics 14, no. 11: 2336. https://doi.org/10.3390/pharmaceutics14112336

Dubinin, M. V., Starinets, V. S., Belosludtseva, N. V., Mikheeva, I. B., Chelyadnikova, Y. A., Igoshkina, A. D., Vafina, A. B., Vedernikov, A. A., & Belosludtsev, K. N. (2022). BK_Ca Activator NS1619 Improves the Structure and Function of Skeletal Muscle Mitochondria in Duchenne Dystrophy. Pharmaceutics, 14(11), 2336. https://doi.org/10.3390/pharmaceutics14112336